gip glp 1 glucagon agonists Frontiers Upcoming wave of hormone-based therapies
Description
Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.
Here's what clinicians should know.
Learn why people explore it and what to consider before trying it.
Its no secret that GLP-1 medications help people lose weight
We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity
Heres what to watch as this $40B+ category continues to grow.
